Market Cap 11.34M
Revenue (ttm) 0.00
Net Income (ttm) -22.14M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.08
Volume 522,100
Avg Vol 374,314
Day's Range N/A - N/A
Shares Out 31.79M
Stochastic %K 18%
Beta 1.07
Analysts Strong Sell
Price Target $6.25

Latest News on CLDI

Innovation In Indexing: Why Passive ETFs Matter

May 22, 2025, 7:43 AM EDT - 16 days ago

Innovation In Indexing: Why Passive ETFs Matter

ELFY INVN OWNB PEVC SPY TOV XIDV


Global X Launches 2 Domestic-Focused ETFs

Apr 16, 2025, 1:44 PM EDT - 7 weeks ago

Global X Launches 2 Domestic-Focused ETFs


Calidi Biotherapeutics Announces Proposed Public Offering

Jan 8, 2025, 4:01 PM EST - 5 months ago

Calidi Biotherapeutics Announces Proposed Public Offering


Calidi to Effect Reverse Stock Split

Jul 5, 2024, 4:15 PM EDT - 1 year ago

Calidi to Effect Reverse Stock Split